C S Graham

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Imported Fasciola hepatica infection in the United States and treatment with triclabendazole
    C S Graham
    Division of Infectious Disease, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Infect Dis 33:1-5. 2001
  2. ncbi Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis
    C S Graham
    Beth Israel Deaconess Medical Center, Harvard Institute of Medicine, One Deaconess Road, Boston, MA 02215, USA
    Clin Infect Dis 33:562-9. 2001

Collaborators

Detail Information

Publications2

  1. ncbi Imported Fasciola hepatica infection in the United States and treatment with triclabendazole
    C S Graham
    Division of Infectious Disease, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Infect Dis 33:1-5. 2001
    ..Triclabendazole is now the recommended drug for treating for fascioliasis because of its efficacy, safety, and ease of use...
  2. ncbi Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis
    C S Graham
    Beth Israel Deaconess Medical Center, Harvard Institute of Medicine, One Deaconess Road, Boston, MA 02215, USA
    Clin Infect Dis 33:562-9. 2001
    ..40-3.07). There is a significantly elevated RR of severe liver disease in persons who are coinfected with HIV and HCV. This has important implications for timely diagnosis and consideration of treatment in coinfected persons...